UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase II Evaluation of Gefitinib in Patients With Newly Diagnosed Grade 4 Astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074

International journal of radiation oncology, biology, physics, 2011-06, Vol.80 (2), p.347-353

2011

Volltextzugriff (PDF)

Efficacy and safety of entrectinib in patients with NTRK fusion-positive (NTRK-fp) Tumors: Pooled analysis of STARTRK-2, STARTRK-1 and ALKA-372-001

Annals of oncology, 2018-10, Vol.29, p.viii713-viii713

2018

Volltextzugriff (PDF)

Entrectinib in NTRK fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of patients (pts) enrolled in STARTRK-2, STARTRK-1 and ALKA-372-001

Annals of oncology, 2019-04, Vol.30, p.ii48-ii49

2019

Volltextzugriff (PDF)

Efficacy and safety of entrectinib in patients with NTRK fusion-positive tumours: Pooled analysis of STARTRK-2, STARTRK-1, and ALKA-372-001

Annals of oncology, 2018-11, Vol.29, p.ix175-ix175

2018

Volltextzugriff (PDF)

Systemic T cell adoptive immunotherapy of malignant gliomas

Journal of neurosurgery, 1998-07, Vol.89 (1), p.42-51

1998

Volltextzugriff (PDF)

Tubulogenesis from isolated single cells of adult mammalian kidney: clonal analysis with a recombinant retrovirus

American journal of physiology. Renal physiology, 1996-07, Vol.271 (1), p.42-F49

1996

Volltextzugriff (PDF)

T cell-mediated tumor rejection displays diverse dependence upon perforin and IFN-gamma mechanisms that cannot be predicted from in vitro T cell characteristics

The Journal of immunology (1950), 2000-12, Vol.165 (12), p.7116-7124

2000

Volltextzugriff (PDF)

Lack of Plasminogen Activator Inhibitor-1 Effect in a Transgenic Mouse Model of Metastatic Melanoma

Blood, 1996-06, Vol.87 (11), p.4718-4722

1996

Volltextzugriff (PDF)

Monocyte chemoattractant protein inhibits the generation of tumor-reactive T cells

Cancer research (Chicago, Ill.), 1997-11, Vol.57 (21), p.4849-4854

1997

Volltextzugriff (PDF)

Reconstitution of antibody-dependent phagocytosis in fibroblasts expressing Fc gamma receptor IIIB and the complement receptor type 3

The Journal of immunology (1950), 1994-08, Vol.153 (4), p.1769-1777

1994

Volltextzugriff (PDF)

Diverse manifestations of tumorigenicity and immunogenicity displayed by the poorly immunogenic B16-BL6 melanoma transduced with cytokine genes

Cancer Immunology, Immunotherapy, 1996-05, Vol.42 (4), p.237-245

1996

Volltextzugriff (PDF)

Targeted Gene Transfer for Adenocarcinoma Using a Combination of Tumor‐specific Antibody and Tissue‐specific Promoter

Cancer science, 1998-11, Vol.89 (11), p.1212-1219

1998

Volltextzugriff (PDF)

MR of myelomatous meningitis

American journal of neuroradiology : AJNR, 1995-06, Vol.16 (6), p.1316-1317

1995

Volltextzugriff (PDF)

Tumor reactivity of immune T cells in short-term culture

Cancer Immunology, Immunotherapy, 1996-12, Vol.43 (4), p.231-239

1996

Volltextzugriff (PDF)

Ex vivo activation of tumor-draining lymph node T cells reverses defects in signal transduction molecules

Cancer Immunology, Immunotherapy, 1998-07, Vol.46 (5), p.268-276

1998

Volltextzugriff (PDF)

Isolation based on L-selectin expression of immune effector T cells derived from tumor-draining lymph nodes

Cancer research (Chicago, Ill.), 1996-10, Vol.56 (19), p.4338-4342

1996

Volltextzugriff (PDF)

446PDPhase I study of AMG 510, a novel molecule targeting KRAS G12C mutant solid tumours

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

Effects of electrical stimulation and upper body training after spinal cord injury

Medicine and science in sports and exercise, 1993-09, Vol.25 (9), p.1054-1061

1993

Volltextzugriff (PDF)

Hematopoietic stem cell gene replacement therapy

Biochimica et biophysica acta, 1992-12, Vol.1114 (2), p.193-207

Krauss, John C.

1992

Volltextzugriff (PDF)

113OEntrectinib in NTRK fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of patients (pts) enrolled in STARTRK-2, STARTRK-1 and ALKA-372-001

Annals of oncology, 2019-04, Vol.30 (Supplement_2)

2019

Volltextzugriff (PDF)

Chronic lymphocytic leukemia: a brief review

Cleveland Clinic journal of medicine, 1998-01, Vol.65 (1), p.42-48

Krauss, J C

1998

Volltextzugriff (PDF)

LBA4Efficacy and safety of entrectinib in patients with NTRK fusion-positive tumours: Pooled analysis of STARTRK-2, STARTRK-1, and ALKA-372-001

Annals of oncology, 2018-11, Vol.29 (suppl_9)

2018

Volltextzugriff (PDF)

LBA17Efficacy and safety of entrectinib in patients with NTRK fusion-positive (NTRK-fp) Tumors: Pooled analysis of STARTRK-2, STARTRK-1 and ALKA-372-001

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Volltextzugriff (PDF)

HabitatSpace: Multidimensional characterization of pelagic essential fish habitat

OCEANS 2009, 2009, p.1-9

2009

Volltextzugriff (PDF)

Enhancement of immune reactivity in the lymph nodes draining a murine melanoma engineered to elaborate interleukin-4

Journal of immunotherapy (1997), 1994-08, Vol.16 (2), p.77-84

1994

Volltextzugriff (PDF)

1 – 25 von 1.713

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.412)
Mit Volltextzugriff
(1.343)

Publikationsform

5 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(984)
Life Sciences & Biomedicine
(658)
Humans
(552)
Female
(331)
Male
(317)
Biological And Medical Sciences
(305)
Physical Sciences
(258)
Medical Sciences
(249)
Adult
(204)
Middle Aged
(198)
Physics
(188)
Animals
(159)
Aged
(157)
Technology
(138)
Neurosciences & Neurology
(117)
Clinical Neurology
(105)
Child
(79)
Fundamental And Applied Biological Sciences. Psychology
(73)
Pharmacology. Drug Treatments
(71)
Adolescent
(70)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Phase II Evaluation of Gefitinib in Patients With Newly Diagnosed Grade 4 Astrocytoma: Mayo/North Central Cancer Treatment Group Study N0074

Efficacy and safety of entrectinib in patients with NTRK fusion-positive (NTRK-fp) Tumors: Pooled analysis of STARTRK-2, STARTRK-1 and ALKA-372-001

Entrectinib in NTRK fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of patients (pts) enrolled in STARTRK-2, STARTRK-1 and ALKA-372-001

Efficacy and safety of entrectinib in patients with NTRK fusion-positive tumours: Pooled analysis of STARTRK-2, STARTRK-1, and ALKA-372-001

Systemic T cell adoptive immunotherapy of malignant gliomas

Tubulogenesis from isolated single cells of adult mammalian kidney: clonal analysis with a recombinant retrovirus

T cell-mediated tumor rejection displays diverse dependence upon perforin and IFN-gamma mechanisms that cannot be predicted from in vitro T cell characteristics

Lack of Plasminogen Activator Inhibitor-1 Effect in a Transgenic Mouse Model of Metastatic Melanoma

Monocyte chemoattractant protein inhibits the generation of tumor-reactive T cells

Reconstitution of antibody-dependent phagocytosis in fibroblasts expressing Fc gamma receptor IIIB and the complement receptor type 3

Diverse manifestations of tumorigenicity and immunogenicity displayed by the poorly immunogenic B16-BL6 melanoma transduced with cytokine genes

Targeted Gene Transfer for Adenocarcinoma Using a Combination of Tumor‐specific Antibody and Tissue‐specific Promoter

MR of myelomatous meningitis

Tumor reactivity of immune T cells in short-term culture

Ex vivo activation of tumor-draining lymph node T cells reverses defects in signal transduction molecules

Isolation based on L-selectin expression of immune effector T cells derived from tumor-draining lymph nodes

446PDPhase I study of AMG 510, a novel molecule targeting KRAS G12C mutant solid tumours

Effects of electrical stimulation and upper body training after spinal cord injury

Hematopoietic stem cell gene replacement therapy

113OEntrectinib in NTRK fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of patients (pts) enrolled in STARTRK-2, STARTRK-1 and ALKA-372-001

Chronic lymphocytic leukemia: a brief review

LBA4Efficacy and safety of entrectinib in patients with NTRK fusion-positive tumours: Pooled analysis of STARTRK-2, STARTRK-1, and ALKA-372-001

LBA17Efficacy and safety of entrectinib in patients with NTRK fusion-positive (NTRK-fp) Tumors: Pooled analysis of STARTRK-2, STARTRK-1 and ALKA-372-001

HabitatSpace: Multidimensional characterization of pelagic essential fish habitat

Enhancement of immune reactivity in the lymph nodes draining a murine melanoma engineered to elaborate interleukin-4

Suchergebnisse filtern